Technical Analysis for ANVS - Annovis Bio, Inc.

Grade Last Price % Change Price Change
C 26.54 0.11% 0.03
ANVS closed up 0.11 percent on Friday, April 9, 2021, on 36 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical ANVS trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.11%
Narrow Range Bar Range Contraction 0.11%
NR7 Range Contraction 0.11%
Older End-of-Day Signals for ANVS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 1 day ago
50 DMA Support 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Mild Novi Psychiatric Diagnosis Amyloid Nervous System Neurodegeneration Alzheimer's Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Gladstone Institutes Parkinson's Diseases

Is ANVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 47.93
52 Week Low 3.08
Average Volume 363,154
200-Day Moving Average 10.92
50-Day Moving Average 26.17
20-Day Moving Average 30.97
10-Day Moving Average 27.82
Average True Range 3.49
ADX 23.49
+DI 19.46
-DI 23.98
Chandelier Exit (Long, 3 ATRs ) 37.47
Chandelier Exit (Short, 3 ATRs ) 35.71
Upper Bollinger Band 38.75
Lower Bollinger Band 23.18
Percent B (%b) 0.22
BandWidth 50.27
MACD Line 0.01
MACD Signal Line 0.99
MACD Histogram -0.9894
Fundamentals Value
Market Cap 182.9 Million
Num Shares 6.89 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -163.22
Price-to-Sales 0.00
Price-to-Book 4.43
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.97
Resistance 3 (R3) 28.81 27.84 28.56
Resistance 2 (R2) 27.84 27.22 27.92 28.43
Resistance 1 (R1) 27.19 26.84 26.71 27.35 28.29
Pivot Point 26.22 26.22 25.98 26.30 26.22
Support 1 (S1) 25.57 25.60 25.09 25.73 24.79
Support 2 (S2) 24.60 25.22 24.68 24.65
Support 3 (S3) 23.95 24.60 24.52
Support 4 (S4) 24.11